Upper-Extremity Deep Vein Thrombosis

Joffe, Hylton V.; Goldhaber, Samuel Z.

doi:10.1161/01.cir.0000031705.57473.1c

Cited by 280 publications

(204 citation statements)

References 45 publications

Supporting

Mentioning

187

Contrasting

Unclassified

Order By: Relevance

“…64 Results from numerous studies have identified the presence of a CVAD as a risk factor for the development of an upper-extremity DVT, 32,[68][69][70] although discrepancies exist concerning the incidence of CVADrelated DVT. 70,71 The association between catheter/ device placement and the development of DVT may be the result of venous stasis and vessel injury after insertion of the CVAD 70,72,73 or infections occurring as a result of catheter placement. 73,74 Possible reasons for the reported discrepancies in the incidence of CVAD-related DVT may include recent improvements in catheter materials and design and the different diagnostic strategies used in some of the studies (ie, clinical, which identifies symptomatic events, vs radiologic surveillance, which identifies symptomatic and asymptomatic events).…”

mentioning

confidence: 99%

Venous Thromboembolic Disease

Streiff¹,

Bockenstedt²,

Cataland³

et al. 2013

J Natl Compr Canc Netw

Self Cite

View full text Add to dashboard Cite

OverviewVenous thromboembolism (VTE) is a common and life-threatening condition in patients with cancer.1,2 Results from a retrospective study of hospitalized adult patients with cancer with neutropenia (N=66,106) showed that approximately 3% to 12% of these patients, depending on the type of malignancy, experienced VTE during their first hospitalization.1 In a recent health claims database analysis of patients undergoing chemotherapy for solid tumors in the ambulatory setting (N=17,284), VTE NCCN Venous Thromboembolic Disease Clinical Practice Guidelines in Oncology AbstractVenous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this complication. Therefore, it is critical to recognize the various risk factors for VTE in patients with cancer. Risk assessment tools are available to help identify patients for whom discussions regarding the potential benefits and risks of thromboprophylaxis would be appropriate. The NCCN Clinical Practice Guidelines in Oncology for VTE provide recommendations on risk evaluation, diagnosis, prevention, and treatment of VTE in patients with cancer. (JNCCN 2013;11:1402-1429 NCCN Categories of Evidence and ConsensusCategory 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate. Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate. These guidelines are also available on the Internet. For the latest update, visit NCCN.org.

show abstract

mentioning

confidence: 99%

Venous Thromboembolic Disease

Streiff¹,

Bockenstedt²,

Cataland³

et al. 2013

J Natl Compr Canc Netw

Self Cite

View full text Add to dashboard Cite

show abstract

“…CT can also be used with an advantage of detecting pulmonary embolism as well as IJVT. Anticoagulation is the mainstay of treatment; it helps to maintain the patency of venous collaterals and prevents subsequent thrombus propagation [2]. There are few indications for surgical intervention and they're usually reserved for more complicated cases.…”

Section: Resultsmentioning

confidence: 99%

“…Internal jugular vein thrombosis (IJVT) is an obscure vascular disease that is not often seen, with potentially deadly complications such as sepsis and pulmonary embolism [1]. Upper extremity DVT is used to be considered as a rare presentation but now can be seen more frequently, owing to the increased use of central venous catheters for chemotherapy or dialysis [2]. However, an isolated internal jugular vein thrombosis is still considered a rare presentation, especially in the absence of predisposing factors.…”

Section: Introductionmentioning

confidence: 99%

Isolated internal jugular vein thrombosis presenting with seizure: a case report

Khattab¹,

Shaikh²,

Hammadi³

et al. 2017

IJMDC

View full text Add to dashboard Cite

show abstract

“…The diagnosis of effort thrombosis should be suspected clinically and confirmed with contrast venography or, as in this case, duplex ultrasonography. [27][28][29] Two unique aspects of this case deserve mention. First, primary effort thrombosis is a rare disorder (2 in 100 000 persons per year) and usually affects the dominant extremity of active individuals.…”

Section: Clinical Diagnosismentioning

confidence: 90%

Unique Treatment Regimen for Effort Thrombosis in the Nondominant Extremity of an Overhead Athlete: A Case Report

Snead

Marberry

Rowdon

2009

Journal of Athletic Training

View full text Add to dashboard Cite

Objective: To advise athletic trainers on the potential for effort thrombosis to occur in nonthrowing athletes and to underscore the importance of early recognition and treatment. Background: An 18-year-old offensive lineman presented with a 1-day history of diffuse shoulder pain with no specific history of injury; swelling and erythema involved the entire left upper extremity. He was immediately referred to the team physician, who suspected deep vein thrombosis and sent the athlete to an imaging center. Duplex ultrasound was obtained on the day of presentation, and he was admitted to the hospital that evening. Differential Diagnosis: Deep vein thrombosis, thoracic outlet syndrome, shoulder tendinitis. Treatment: Anticoagulation with heparin was administered at the hospital, and he was sent home the next day on subcutaneous enoxaparin sodium, followed by a 5-mg daily dose of oral warfarin sodium. Oral anticoagulants were continued for a total of 4 weeks. The athlete began upper body lifting and was released 5 weeks postinjury to gradually return to football without restrictions. Uniqueness: Effort thrombosis is typically seen in the dominant arm of athletes, and the current treatment protocol calls for thrombolysis or surgical intervention. This athlete, whose position required repeated elevation of his arms in forward flexion, sustained the injury in his nondominant arm, was treated with anticoagulation only, and had a full return to football. At 18-month follow-up, he had no recurrence of symptoms. Conclusions: Early recognition and treatment of athletes with effort thrombosis is paramount to a successful clinical outcome and prompt return to play.

show abstract

Upper-Extremity Deep Vein Thrombosis

Cited by 280 publications

References 45 publications

Venous Thromboembolic Disease

Venous Thromboembolic Disease

Isolated internal jugular vein thrombosis presenting with seizure: a case report

Unique Treatment Regimen for Effort Thrombosis in the Nondominant Extremity of an Overhead Athlete: A Case Report

Contact Info

Product

Resources

About